Publications

Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise

J. E. Pinkser, A. J. Laguna Sanz, J. B. Lee, M. M. Church, C. Andre, L. E. Lindsey, F. J. Doyle III, and E. Dassau. Diabetes Technology and Therapeutics, 20(7), 2018.

Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm with Mini-Dose Stable Glucagon Delivery in Post-Bariatric Hypoglycemia

Laguna Sanz Alejandro J., Mulla Christopher M., Fowler Kristen M., Cloutier Emilie, Goldfine Allison B., Newswanger Brett, Cummins Martin, Deshpande Sunil, Prestrelski Steven J., Strange Poul, Zisser Howard, Doyle Francis J. III, Dassau Eyal, and Patti Mary-Elizabeth. Diabetes Technology & Therapeutics. February 2018, 20(2): 127-139.

12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia

Eyal Dassau, Jordan E. Pinsker, Yogish C. Kudva, Sue A. Brown, Ravi Gondhalekar, Chiara Dalla Man, Steve Patek, Michele Schiavon, Vikash Dadlani, Isuru Dasanayake, Mei Mei Church, Rickey E. Carter, Wendy C. Bevier, Lauren M. Huyett, Jonathan Hughes, Stacey Anderson, Dayu Lv, Elaine Schertz, Emma Emory, Shelly K. McCrady-Spitzer, Tyler Jean, Paige K. Bradley, Ling Hinshaw, Alejandro J. Laguna Sanz, Ananda Basu, Boris Kovatchev, Claudio Cobelli and Francis J. Doyle III. “12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.” Diabetes Care (2017): dc171188. doi:10.2337/dc17-1188